Chlorhexidine gluconate - Dexcel Pharma

Drug Profile

Chlorhexidine gluconate - Dexcel Pharma

Alternative Names: Chlorhexidine gluconate chip; PerioChip

Latest Information Update: 06 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dexcel-Pharma
  • Class Anti-infectives; Antiseptics; Biguanides; Small molecules
  • Mechanism of Action Bacterial capsule modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Periodontitis
  • Phase III Peri-implantitis

Most Recent Events

  • 06 Sep 2017 Chlorhexidine gluconate is still in a phase III trial for Peri-implantitis in Germany, Israel, USA and United Kingdom (NCT02080403)
  • 01 Jul 2014 Phase-III clinical trials in Peri-implantitis in Germany (Subgingival)
  • 01 Jul 2014 Phase-III clinical trials in Peri-implantitis in Israel (Subgingival)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top